Humatin (Paromomycin Sulfate)

Humatin is an oral, prescription‑only medication that contains the active ingredient paromomycin sulfate. It is marketed in the European Union and belongs to the aminoglycoside antibiotic class, used primarily for treating intestinal protozoal infections and certain bacterial diarrheas.

Humatin is indicated for several gastrointestinal and parasitic conditions where the causative organisms are susceptible to paromomycin. - Intestinal amoebiasis caused by Entamoeba histolytica - Giardiasis (Giardia lamblia infection) - Travelers' diarrhea due to susceptible bacterial strains - Off‑label use for cutaneous leishmaniasis in some clinical settings - Prevention of infection in high‑risk travel scenarios

Adverse reactions to Humatin vary in frequency and severity.

Common: - Nausea - Vomiting - Diarrhea - Abdominal cramps - Metallic taste in the mouth - Mild skin rash

Serious: - Severe allergic reactions (anaphylaxis, angioedema) - Ototoxicity (hearing loss, tinnitus) - Nephrotoxicity (renal impairment) - Severe electrolyte disturbances

Before prescribing Humatin, clinicians should consider several safety factors. - Assess renal function, especially in patients with pre‑existing kidney disease. - Use caution in individuals with known hearing impairment or vestibular disorders. - Monitor for signs of hypersensitivity during treatment. - Pregnancy and lactation status are unknown; weigh potential risks and benefits. - Adjust dosage in elderly patients due to altered pharmacokinetics. - Ensure the infection is confirmed to be susceptible to paromomycin before initiating therapy.

Humatin may interact with other medicines, affecting efficacy or safety.

Avoid: - Concurrent use of other nephrotoxic agents (e.g., aminoglycoside antibiotics, vancomycin, loop diuretics). - Co‑administration with ototoxic drugs (e.g., loop diuretics, certain chemotherapeutics).

Use with caution: - Antacids containing magnesium or aluminum, which can reduce absorption. - Neuromuscular blocking agents, as paromomycin may potentiate their effects. - Other oral antibiotics that may alter gut flora and affect drug absorption. - Medications cleared renally, requiring dose adjustments based on renal function.